Mostrar registro simples

dc.contributor.authorOliveira, Rodrigo Bueno de (Médico)pt_BR
dc.contributor.authorBarreto, Fellype de Carvalhopt_BR
dc.contributor.authorCustódio, Melani Ribeiropt_BR
dc.contributor.authorGueiros, José Edevanilson Barrospt_BR
dc.contributor.authorNeves, Carolina Larapt_BR
dc.contributor.authorKarohl, Cristinapt_BR
dc.contributor.authorSampaio, Elisa de Albuquerquept_BR
dc.contributor.authorCosta, Rackel Mota dapt_BR
dc.contributor.authorCanziani, Maria Eugêniapt_BR
dc.contributor.authorMoysés, Rosa Maria Affonsopt_BR
dc.contributor.authorCarvalho, Aluízio Barbosapt_BR
dc.date.accessioned2018-11-28T02:45:30Zpt_BR
dc.date.issued2014pt_BR
dc.identifier.issn0101-2800pt_BR
dc.identifier.urihttp://hdl.handle.net/10183/185153pt_BR
dc.description.abstractMineral bone disorder (MBD) is a common condition in chronic kidney disease (CKD) patients and causes significant morbidity and mortality. Data involving prevalence of alterations in bone histological patterns, impact of different treatments and its repercussion in outcomes, such as bone fractures, hospitalization, cardiovascular disease and mortality, are scarce. Data bank registry can be a valuable tool to understand epidemiological aspects of MBD CKD. The Brazilian Registry of Bone Biopsy (REBRABO) will be a national registry, coordinating by the Brazilian Society of Nephrology - Committee of MBD-CKD. Objective: To describe REBRABO´s design, elements of data and methodology. Methods: Will be an online national observational and multicentric data registry divided in two phases (retrospective, 1st phase) and prospective (2nd phase), including information from bone tissue histomorphometric analysis and demographics, clinical and laboratorial data from CKD-MBD patients. Results: The REBRABO´s first phase will explore data on demographics, clinical, laboratorial and bone histomorphometric analysis data from January/1986 to December/2013. The first results are expected in early 2015. Conclusion: Studies in the field of CKD-MBD are needed, particularly those analyzing its prevalence, associations between demographic, clinical, histological parameters, and major outcomes. The REBRABO will be a unique retrospective and prospective research platform including bone biopsy data in CKD-MBD patients.en
dc.format.mimetypeapplication/pdfpt_BR
dc.language.isoporpt_BR
dc.relation.ispartofJornal brasileiro de nefrologia. São Paulo. vol. 36, n. 3 (jul./set. 2014), p. 352-359pt_BR
dc.rightsOpen Accessen
dc.subjectDoenças ósseaspt_BR
dc.subjectBone diseasesen
dc.subjectInsuficiência renal crônicapt_BR
dc.subjectElectronic health recordsen
dc.subjectRenal insufficiencyen
dc.subjectRegistros eletrônicos de saúdept_BR
dc.subjectChronicen
dc.titleBrazilian Registry of Bone Biopsy (REBRABO) : design, data elements and methodologypt_BR
dc.typeArtigo de periódicopt_BR
dc.identifier.nrb001081802pt_BR
dc.type.originNacionalpt_BR


Thumbnail
   

Este item está licenciado na Creative Commons License

Mostrar registro simples